Home Careers Contact

Price: 3.15

Change: 0.00

Day High: 3.20
Day Low: 3.10
Volume: 548,047

4:00 PM ET | Sep 25, 2017
Delayed 20 min., by eSignal.



Shareholder Tools

Press Releases

Company News
View Summary Cempra Announces Presentations at Upcoming Investor Conferences and Provides Merger Process Update
Sep 7, 2017
PDF 28.3 KB Add to Briefcase
View Summary Cempra and Melinta Announce Merger to Form Leading, Vertically Integrated Commercial-Stage Anti-Infectives Company
Aug 9, 2017
PDF 41.4 KB Add to Briefcase
View Summary Cempra Provides Corporate Update and Reports Second Quarter 2017 Financial Results
Aug 9, 2017
PDF 31.1 KB Add to Briefcase
View Summary Cempra to Report Second Quarter 2017 Financial Results
Jul 20, 2017
PDF 13.9 KB Add to Briefcase
View Summary Eight Presentations at ASM Microbe Include Late Breaker From Cempra's Phase 3 Fusidic Acid Study and Solithromycin Data on Gonorrhea and Otitis Media
Jun 2, 2017
PDF 19.3 KB Add to Briefcase
View Summary Cempra to Present at the Jefferies 2017 Global Healthcare Conference
Jun 2, 2017
PDF 13.7 KB Add to Briefcase
View Summary Cempra Presents Data on Ophthalmic Solithromycin at ARVO
May 10, 2017
PDF 16.3 KB Add to Briefcase
View Summary Cempra Reports First Quarter 2017 Financial Results and Provides Corporate Update
Apr 28, 2017
PDF 25.8 KB Add to Briefcase
View Summary Cempra Presents Data at ECCMID Highlighting Need for New CABP Therapies and Activity of Solithromycin in Key Population Groups
Apr 21, 2017
PDF 18.9 KB Add to Briefcase
View Summary Cempra to Report First Quarter 2017 Financial Results
Apr 13, 2017
PDF 13.8 KB Add to Briefcase
Showing 1-10 of 238 Page: 1 2 3 4 5 ... 24  Next 10
Add to Briefcase = add release to Briefcase